Brief: Crescita Therapeutics Announces Intention To Make Normal Course Issuer Bid
18/06/2019 01:20
June 17 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS INC. ANNOUNCES INTENTION TO MAKE
NORMAL
COURSE ISSUER BID
* COMPANY'S NORMAL COURSE ISSUER BID IS EXPECTED TO BE FOR
UP TO 1
MILLION SHARES, OR ABOUT 6% OF ITS PUBLIC FLOAT
Source text for Eikon: ID:nCNWyJHJMa
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium